Awareness and Experience of Direct Healthcare Professional Communication and Risk Management Plan Educational Material among Healthcare Professionals in Finland
This research reinforces and complements our previous findings on the need to enhance PhV awareness and expertise among HCPs, particularly in areas such as adverse drug reaction (ADR) reporting, additional monitoring, DHPCs, and RMP educational material. Future DHPCs and RMP educational materials should be made more distinguishable to effectively capture HCPs' attention.
Authors
- Mia Sivén (ORCID: https://orcid.org/0000-0003-2586-1117)
- Andreas Sandberg (ORCID: https://orcid.org/0000-0001-9703-0406)
- Pauliina I. Ehlers
- Heli A. Sandberg
- Anu J. Aallos
- Kari M. Katajisto
Institutions
- University of Helsinki (FI)
- University of Eastern Finland (FI)
- Tesi (Finland) (FI)
- Glaxosmithkline (Finland) (FI)
- Pharmatest (Finland) (FI)
Publication Details
- Journal
- Pharmaceutical Medicine
- Published
- 2025-08-25
- DOI
- https://doi.org/10.1007/s40290-025-00580-z
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Helsingin Yliopisto
- Helsingin ja Uudenmaan Sairaanhoitopiiri